The topical treatment had no significant effect on total or central corneal fluorescence staining score.

D-150 is a potential backbone therapy that is designed to provide multi-year sustained delivery of anti-VEGF (aflibercept and ...

“We remain committed to bringing an ophthalmic bevacizumab to market in the United States and providing retina patients suffering from wet AMD with a much needed treatment option that has the ...

It arrived hot and looked pretty tempting. First I got stuck into the margherita, which was very wet. It was also piping hot and a bit hard to eat with the top layer of solidifying cheese trying to ...

It arrived hot and looked pretty tempting. First I got stuck into the margherita, which was very wet. It was also piping hot and a bit hard to eat with the top layer of solidifying cheese trying ...

AMD's new FidelityFX Super Resolution (FSR) 4 frame-gen software offers massive updates for the Radeon 9070 and 9070 XT discrete GPUs, allowing AMD's new GPUs up to 3.7x better performance over ...

The parasites thrive in wet conditions and so wet summers – and more so wet autumns – are a high risk for fluke. It’s important to distinguish between the two different types of fluke. Liver fluke ...

4D Molecular Therapeutics reports positive interim data for 4D-150 in wet AMD and DME, with strong financial position and strategic focus. 4D Molecular Therapeutics announced positive interim data ...

seeking approval of ONS-5010 for the treatment of wet age-related macular degeneration or wet AMD. ONS-5010, an ophthalmic formulation of bevacizumab, received approval in the EU in May 2024 and ...

(RTTNews) - Outlook Therapeutics, Inc. (OTLK), Friday said it has resubmitted its Biologics License Application (BLA) to the U.S.Food and Drug Administration or FDA for ONS-5010 to treat wet age ...

“We remain committed to bringing an ophthalmic bevacizumab to market in the United States and providing retina patients suffering from wet AMD with a much needed treatment option that has the ...